NICE guidance in schizophrenia: how generalisable are drug trials?
Open Access
- 1 June 2006
- journal article
- Published by Royal College of Psychiatrists in Psychiatric Bulletin
- Vol. 30 (6), 210-212
- https://doi.org/10.1192/pb.30.6.210
Abstract
AIMS AND METHODKeywords
This publication has 8 references indexed in Scilit:
- Heavy users of acute psychiatric beds: randomized controlled trial of enhanced community management in an outer London borough.Psychological Medicine, 2002
- Prevention of Relapse in SchizophreniaNew England Journal of Medicine, 2002
- A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with SchizophreniaNew England Journal of Medicine, 2002
- Content and quality of 2000 controlled trials in schizophrenia over 50 yearsBMJ, 1998
- Depressive Signs and Symptoms in SchizophreniaArchives of General Psychiatry, 1998
- Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialAmerican Journal of Psychiatry, 1997
- Principal components and further possibilities with the PANSSActa Psychiatrica Scandinavica, 1995
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979